Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapy
Science · 11.10.2024 · 386 (6718)
DOI: 10.1126/science.adl4492 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 11.10.2024. Verfasst von Tae Gun Kang und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Clonal Hematopoiesis, Dioxygenases, DNA Methyltransferase 3A. Die Arbeit wurde bisher 99-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Epigenetic reinforcement of T cell exhaustion is known to be a major barrier limiting T cell responses during immunotherapy. However, the core epigenetic regulators restricting antitumor immunity during prolonged antigen exposure are not clear. We investigated three commonly mutated epigenetic regulators that promote clonal hematopoiesis to determine whether they affect T cell stemness and response to checkpoint blockade immunotherapy. CD8 T cells lacking Dnmt3a, Tet2, or Asxl1 preserved a progenitor-exhausted (Tpex) population for more than 1 year during chronic antigen exposure without undergoing malignant transformation. Asxl1 controlled the self-renewal capacity of T cells and reduced CD8 T cell differentiation through H2AK119 ubiquitination and epigenetic modification of the polycomb group–repressive deubiquitinase pathway. Asxl1-deficient T cells synergized with anti–PD-L1 immunotherapy to improve tumor control in experimental models and conferred a survival advantage to mutated T cells from treated patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
- College of Graduate Health Sciences, University of Tennessee Health Science Center, Memphis, TN 38105, USA.
- Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
- Department of Hematology, Rigshospitalet, Copenhagen University Hospital, DK-2100 Copenhagen, Denmark.
- Biotech Research and Innovation Center (BRIC), University of Copenhagen, DK-2200 Copenhagen, Denmark.
- Department of Epigenetics, Van Andel Institute, Grand Rapids, MI 49503, USA.
ORCID-Profile: Tae Gun Kang, Xin Lan, Tian Mi, Hongfeng Chen, Shanta Alli, Song-Eun Lim, Sheetal Bhatara, Anoop Babu Vasandan, Grace Ward, Sofia Bentivegna, Josh Jang, Marianne L Spatz, Jin-Hwan Han, Balthasar Clemens Schlotmann, Jakob Schmidt Jespersen, Christopher Derenzo, Peter Vogel, Jiyang Yu, Stephen Baylin, Peter Jones, Casey O'Connell, Kirsten Grønbæk, Ben Youngblood, Caitlin C Zebley
Förderung
- NIAID NIH HHS
- NCI NIH HHS
Zitieren
APA
Kang, T. G., Lan, X., Mi, T., Chen, H., Alli, S., Lim, S. E., Bhatara, S., Vasandan, A. B., Ward, G., Bentivegna, S., Jang, J., Spatz, M. L., Han, J. H., Schlotmann, B. C., Jespersen, J. S., Derenzo, C., Vogel, P., Yu, J., Baylin, S., …, & Zebley, C. C. (2024). Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapy. Science, 386(6718). https://doi.org/10.1126/science.adl4492
Vancouver
Kang TG, Lan X, Mi T, Chen H, Alli S, Lim SE, et al. Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapy. Science. 2024;386(6718). doi:10.1126/science.adl4492
BibTeX
@article{Kang2024,
author = {Kang, Tae Gun and Lan, Xin and Mi, Tian and Chen, Hongfeng and Alli, Shanta and Lim, Song-Eun and Bhatara, Sheetal and Vasandan, Anoop Babu and Ward, Grace and Bentivegna, Sofia and Jang, Josh and Spatz, Marianne L and Han, Jin-Hwan and Schlotmann, Balthasar Clemens and Jespersen, Jakob Schmidt and Derenzo, Christopher and Vogel, Peter and Yu, Jiyang and Baylin, Stephen and Jones, Peter and O'Connell, Casey and Grønbæk, Kirsten and Youngblood, Ben and Zebley, Caitlin C},
title = {Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapy},
journal = {Science},
year = {2024},
volume = {386},
number = {6718},
doi = {10.1126/science.adl4492}
}
EUVIMED